Quotient Wealth Partners LLC Increases Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Quotient Wealth Partners LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 860 shares of the company’s stock after purchasing an additional 38 shares during the period. Quotient Wealth Partners LLC’s holdings in HCA Healthcare were worth $350,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after acquiring an additional 60,304 shares in the last quarter. Wellington Management Group LLP lifted its holdings in HCA Healthcare by 1.7% in the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after buying an additional 170,560 shares during the period. Capital World Investors raised its position in shares of HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after acquiring an additional 1,019,750 shares in the last quarter. Royal London Asset Management Ltd. boosted its position in shares of HCA Healthcare by 11.9% during the fourth quarter. Royal London Asset Management Ltd. now owns 1,474,238 shares of the company’s stock valued at $399,047,000 after purchasing an additional 156,757 shares in the last quarter. Finally, Darsana Capital Partners LP lifted its position in HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares during the period. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on HCA. UBS Group upped their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Morgan Stanley began coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target for the company. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Finally, Oppenheimer increased their price objective on HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $359.89.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $387.25 on Friday. The company has a 50 day moving average price of $385.90 and a 200-day moving average price of $346.88. The company has a market capitalization of $99.94 billion, a PE ratio of 18.18, a P/E/G ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $409.42. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.29 earnings per share. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 22.51 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were given a dividend of $0.66 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.68%. HCA Healthcare’s dividend payout ratio (DPR) is 12.39%.

Insider Buying and Selling

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.